Processing

Please wait...

Settings

Settings

Goto Application

1. WO2017220047 - FORMULATION TREATING JOINT ACHE

Publication Number WO/2017/220047
Publication Date 28.12.2017
International Application No. PCT/CN2017/097782
International Filing Date 17.08.2017
IPC
A61K 36/9066 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
906Zingiberaceae (Ginger family)
9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
A61K 35/60 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
56Materials from animals other than mammals
60Fish, e.g. seahorses; Fish eggs
A61K 35/32 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
A61P 19/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 19/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
08for bone diseases, e.g. rachitism, Paget's disease
A61P 29/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
CPC
A61K 35/32
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
A61K 35/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
56Materials from animals other than mammals
60Fish, e.g. seahorses; Fish eggs
A61K 36/076
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
076Poria
A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
A61K 36/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
A61K 36/258
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
258Panax (ginseng)
Applicants
  • 赵吉永 ZHAO, Jiyong [CN]/[CN]
Inventors
  • 崔坤峰 CUI, Kunfeng
Priority Data
201610452732.321.06.2016CN
Publication Language Chinese (zh)
Filing Language Chinese (ZH)
Designated States
Title
(EN) FORMULATION TREATING JOINT ACHE
(FR) FORMULATION POUR LE TRAITEMENT DE DOULEURS ARTICULAIRES
(ZH) 一种治疗骨节酸痛配方
Abstract
(EN) Disclosed is a formulation treating joint ache, said formulation comprising oral formulation and external heat treatment components. The oral formulation components are as follows, by gram: 1-10 grams of poria, 1-10 grams of radix astragali, 1-10 grams of fructus schisandrae, 1-10 grams of radix codonopsis, 5-15 grams of sheep bone, 5-20 grams of ox marrow, 1-15 grams of bulbus allii macrostemi, 1-10 grams of fructus aurantii, 1-15 grams of semen persicae, 1-15 grams of panax notoginseng, 1-5 grams of folium ginkgo, 1-15 grams of radix aucklandiae, 5-15 grams of retinervus luffae fructus, 1-10 grams of flos carthami, 1-15 grams of herba abri, 1-15 grams of caulis spatholobi, and 1-15 grams of herba plantaginis. The external heat treatment components are as follows, by gram: 5-25 grams of rhizoma atractylodis, 5-15 grams of caulis spatholobi, 1-20 grams of semen strychni, 5-15 grams of herba plantaginis, 5-10 grams of ginger, 5-10 grams of pericarpium citri reticulatae, and 5-10 grams of radix bupleuri. The formulation treating joint ache uses oral and external local heat treatment means for internal and external administration, improving a treatment effect. The oral formulation components ease pain at the affected area. The formulation uses supplementation means to treat qi and blood stagnation and blood stasis and coagulation, improves immunity and metabolism, and reduces the possibility of relapse.
(FR) L'invention concerne une formulation pour le traitement de douleurs articulaires, ladite formulation comprenant une formulation orale et des constituants externes de traitement thermique. Les constituants de la formulation orale sont comme suit, en grammes : de 1 à 10 grammes de poria, de 1 à 10 grammes de radix astragali, de 1 à 10 grammes de fructus schisandrae, de 1 à 10 grammes de radix codonopsis, de 5 à 15 grammes d'os de mouton, de 5 à 20 grammes de moelle de bœuf, de 1 à 15 grammes de bulbus allii macrostemi, de 1 à 10 grammes de fructus aurantii, de 1 à 15 grammes de semence de persicae, de 1 à 15 grammes de panax notoginseng, de 1 à 5 grammes de folium ginkgo, de 1 à 15 grammes de radix aucklandiae, de 5 à 15 grammes de retinervus luffae fructus, de 1 à 10 grammes de flos carthami, de 1 à 15 grammes d'herba abri, de 1 à 15 grammes de caulis spatholobi, et de 1 à 15 grammes d'herba plantaginis. Les constituants externes de traitement thermique sont comme suit, en grammes : de 5 à 25 grammes de rhizoma atractylodis, de 5 à 15 grammes de caulis spatholobi, de 1 à 20 grammes de semence de strychni, de 5 à 15 grammes d'herba plantaginis, de 5 à 10 grammes de gingembre, de 5 à 10 grammes de pericarpium citri reticulatae, et de 5 à 10 grammes de radix bupleuri. La formulation pour le traitement des douleurs articulaires utilise des moyens de traitement thermique locaux par voie orale et externe pour une administration par voie interne et externe, améliorant ainsi un effet de traitement. Les constituants de la formulation orale atténuent la douleur au niveau de la zone touchée. La formulation utilise des moyens de supplémentation pour traiter la stagnation du qi et du sang ainsi que la stase et la coagulation du sang, améliore l'immunité et le métabolisme, et réduit la possibilité de rechute.
(ZH) 本发明公开了一种治疗骨节酸痛配方,所述配方包括内服配方和外部热疗组份;所述内服配方组份以克计量如下:茯苓1~10g、黄芪1~10g、五味子1~10g,党参1~10g、羊骨5~15g、牛骨髓5~20g、薤白1~15g、枳壳1~10g、桃仁1~15g、参三七1~15g、银杏叶1~5g、木香1~15g、丝瓜络5~15g、红花1~10g、鸡骨草1~15g、鸡血藤1~15g、车前草1~15g;所述外部热疗组份以克计量如下:苍术5~25g、鸡血藤5~15g、马钱子1~20g、车前草5~15g、姜片5~10g、陈皮5~10g、柴胡5~10g。本发明的治疗骨节酸痛配方,其采用内服和外部局部热疗方式进行内外给药,提高好的治疗效果;其通过内服配方组份能够环节病症处疼痛;同时采用以通代补的方式,治疗气血阻滞和淤血凝聚;另外其能够提高免疫力和新陈代谢能力,减小复发可能。
Related patent documents
Latest bibliographic data on file with the International Bureau